Lei Li

Title: Lei Li - Innovator in Nucleic Acid Research

Introduction

Lei Li is a prominent inventor based in Baltimore, MD (US). He has made significant contributions to the field of nucleic acid research, particularly in the development of novel compounds for cancer treatment. With a total of 2 patents, his work is paving the way for innovative therapeutic approaches.

Latest Patents

Lei Li's latest patents include a dinuclear copper-based compound and ligand for nucleic acid scission and anticancer treatment. The first patent describes a novel method for oxidizing or splitting nucleic acids at specific points on a complementary nucleic acid segment using a dinuclear copper-based compound of Formula I. This invention also relates to a new treatment for cancer, tumors, and cancer cells utilizing the same dinuclear copper-based compound or a naked ligand of Formula II. The second patent similarly focuses on the method for splitting nucleic acids at specific points, reinforcing the potential of these compounds in cancer therapy.

Career Highlights

Throughout his career, Lei Li has worked with esteemed institutions such as the University System of Maryland and Johns Hopkins University. His research has garnered attention for its innovative approach to addressing complex biological challenges.

Collaborations

Lei Li has collaborated with notable colleagues, including Steven E. Rokita and Narasimha N. Murthy. These partnerships have contributed to the advancement of his research and the development of his patented technologies.

Conclusion

In summary, Lei Li is an influential inventor whose work in nucleic acid research and cancer treatment is making a significant impact. His innovative patents and collaborations highlight his commitment to advancing medical science.